Centre Testing International Group (300012) Fundamentals 2026 — P/E 21.0x, Revenue Analysis | SniperIQ
Centre Testing International Group (300012) is a CN-listed Industrials company in Consulting Services with a market capitalization of ¥22.6B, trading at ¥13.43 on the SHZ. This SniperIQ fundamentals page covers Centre Testing International Group's valuation (P/E 21.0x, P/B 2.9x), profitability (net margin 15.5%), revenue (¥6.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Centre Testing International Group's market cap?
Centre Testing International Group (300012) has a market capitalization of approximately ¥22.6B, trading at ¥13.43 on the SHZ. Market cap moves with the live share price.
What is Centre Testing International Group's P/E ratio?
Centre Testing International Group's trailing twelve-month P/E ratio is 21.0x, with a price-to-book (P/B) of 2.9x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Centre Testing International Group?
Centre Testing International Group runs a net profit margin of 15.5%, a gross margin of 48.5%, and an operating margin of 16.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Centre Testing International Group generate?
Centre Testing International Group reported revenue of ¥6.6B for fiscal year 2025, with net income of ¥1.0B and earnings per share (EPS) of 0.61. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Centre Testing International Group pay a dividend?
Centre Testing International Group offers a trailing dividend yield of about 1.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Centre Testing International Group financially healthy?
Centre Testing International Group carries a debt-to-equity ratio of 0.06x and a current ratio of 2.50x, with a market beta of 0.95. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Centre Testing International Group a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Centre Testing International Group (300012) the key facts are: market cap ¥22.6B, P/E 21.0x, revenue ¥6.6B, 52-week range 12.1-17.97. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Centre Testing International Group's full fundamentals live
Get Centre Testing International Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.